4.3700
+0.1000
+(2.34%)
At close: April 17 at 4:00:02 PM EDT
4.3900
+0.02
+(0.46%)
After hours: April 17 at 7:46:30 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-207,791
-207,791
-153,624
-118,638
-58,763
Investing Cash Flow
38,276
38,276
-97,824
-124,718
-1,719
Financing Cash Flow
214,451
214,451
163,536
163,558
37,976
End Cash Position
98,165
98,165
53,229
141,141
220,939
Capital Expenditure
-573
-573
-2,796
-6,863
-1,719
Issuance of Capital Stock
213,336
213,336
161,819
161,945
38,006
Free Cash Flow
-208,364
-208,364
-156,420
-125,501
-60,482
12/31/2021 - 3/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BPMC Blueprint Medicines Corporation
84.69
+3.14%
VRDN Viridian Therapeutics, Inc.
13.13
+3.79%
EWTX Edgewise Therapeutics, Inc.
13.45
+3.22%
ORIC ORIC Pharmaceuticals, Inc.
4.7700
+1.71%
BCYC Bicycle Therapeutics plc
7.39
-1.34%
MLTX MoonLake Immunotherapeutics
38.33
+3.67%
APGE Apogee Therapeutics, Inc.
33.11
+3.34%
ERAS Erasca, Inc.
1.1600
-0.85%
DYN Dyne Therapeutics, Inc.
8.17
+4.34%
OLMA Olema Pharmaceuticals, Inc.
4.4200
+3.76%